Patents Assigned to DEVIREX AG
  • Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
    Patent number: 9814743
    Abstract: The present invention pertains generally to the field of therapy, and more specifically to the field of therapy for herpes simplex and herpes zoster, and more particularly, to methods of reducing the rate of relapse, delaying relapse, and/or preventing relapse of herpes labialis (cold sores on the lips), herpes genitalis (genital herpes), and herpes zoster (shingles, zona), by topical administration of polyethylene glycol (PEG), or a composition comprising PEG.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: November 14, 2017
    Assignee: DEVIREX AG
    Inventors: Peter Vitins, Marcel Langenauer, Paul Martin Scherer
  • Polyethylene Glycol Compositions for Controlling Relapse of Herpes Labialis, Herpes Genitalis, and Herpes Zoster
    Publication number: 20130090389
    Abstract: The present invention pertains generally to the field of therapy, and more specifically to the field of therapy for herpes simplex and herpes zoster, and more particularly, to methods of reducing the rate of relapse, delaying relapse, and/or preventing relapse of herpes labialis (cold sores on the lips), herpes genitalis (genital herpes), and herpes zoster (shingles, zona), by topical administration of polyethylene glycol (PEG), or a composition comprising PEG.
    Type: Application
    Filed: July 8, 2011
    Publication date: April 11, 2013
    Applicant: DEVIREX AG
    Inventors: Peter Vitins, Marcel Langenauer, Paul Martin Scherer